Patients who died from ductal breast carcinoma (p = 2.72 × 10−6, Fold Change: 2.136) and acute myeloid leukemia (p = 7.99 × 10−5, Fold Change: 2.655) had enhanced MEAK7 expression (Figures S1B and S1C) (Rhodes et al., 2004). This evidence concerns the gene MEAK7 and breast ductal adenocarcinoma.